Dr. Brad Lindell explains how the Junior Faculty Award allowed his lab to build a large multi-omics sepsis dataset that may help researchers identify novel proteomic signatures related to high-risk adverse events.
The overall goal of the Lindell Lab is to leverage translational immunology to define “treatable traits” in pediatric sepsis patients which can inform novel approaches to precision immunomodulation.
